Your health is personal.
So why isn't your treatment?
Physicians currently determine your medicine dose based upon your body weight or size. This approach poorly considers the large variability in how individual patients distribute, break-down and clear drugs from the body.
There are many complicating factors which contribute to these differences, including gender, age, ethnicity, nutrition and well-being. None of these are accounted for using traditional dosing approaches.
This leads to irregularity and fluctuations between patients in terms of how much drug is in the blood and how long the drug stays there - also known as medicine exposure.
Such practices have led to many patients suffering from poorly treated conditions or dealing with life-limiting side effects associated with critical medicine.
Who we help
Patients groups especially disadvantaged with the ‘one size fits all’ dosing approach include:
Paediatrics (under 16 years of age)
Patients on dose intense regimens
Geriatrics (over 65 years of age)
Patients with rare genetic disorders
Small and large physiques
Patients on narrow therapeutic index drugs
Vesynta elevates medicine safety and effectiveness for these groups and others.
Our team is revolutionising bedside patient monitoring to generate medicine exposure data,
that enables individualised treatment for better health outcomes.
Physicians require a reliable method to aid routine treatment modifications according to individual patient response.
A lack of real-time patient data makes this practice a clinical challenge.
Vesynta's platform is developed in partnership with world leaders in drug monitoring and clinical pharmacology.
Vesynta's technology combines automated desktop hardware with analytical software to provide a universal bedside platform for medicine exposure analysis from patient blood.
This information provides the clinician with an understanding of the patient's pharmacology to support smarter clinical decisions that are tailored to the individual.
Our data-guided dosing approach ensures the best possible treatment against all clinical endpoints, across all patients and medicines.
The value of bedside
Earlier medicines optimisation Personalised dose modifications to safer and more effective levels
Improving patient life quality
Reducing adverse events and sub-optimal treatment
Ensure data quality and security
Reliable response prediction and continuous refinement
Champion care standards
Focus on under-represented patients such as children
Empower patients and physicians
Full treatment ownership is provided via point-of-care access, ease of use and automation